Acquired hypothalamic obesity diagnosis
Fact-checked by Diagnosing acquired hypothalamic obesity (aHO) usually involves identifying a tumor, injury, or other event that may damage an area of the brain called the hypothalamus. This type of damage can lead to aHO symptoms, including rapid weight gain.
The hypothalamus serves as a link between the nervous and endocrine systems, a network of glands and organs that produce and release hormones to control processes throughout the body. It helps regulate appetite and energy use, so hypothalamic dysfunction can contribute to obesity.
Confirming an aHO diagnosis may require brain scans to detect hypothalamic damage, blood tests to assess hormone levels, and a thorough evaluation of symptoms and medical history. Doctors also need to rule out other possible causes of obesity during the diagnosis process.
Signs and symptoms leading to a diagnosis
International guidelines for diagnosing aHO identify these key features:
- a tumor, traumatic injury, or other event that damages the hypothalamus
- rapid, sustained, and clinically significant weight gain
- obesity exceeding a certain threshold
To identify aHO, it is important to connect weight gain to hypothalamic injury. Certain types of brain tumors and their treatments, including surgery and radiation, are the most common causes of hypothalamic damage in aHO. Doctors may recommend monitoring for rapid weight gain after a brain tumor is identified near the hypothalamus, or if other hypothalamic damage occurs.
Weight gain after these events is usually rapid, often beginning within a few months to a year, and may persist for years.
Doctors must also determine that the weight gain is clinically significant and meets certain obesity thresholds. This is usually measured using the body mass index (BMI), a ratio of weight and height that is commonly used as a measure of body fat.
Other early symptoms that can suggest aHO in people with hypothalamic damage may include:
- sleep disruptions
- decreased physical activity
- feeling excessively hungry
Diagnostic process
If key signs and symptoms are present, doctors may carry out an aHO workup to confirm the diagnosis, which may include:
- MRI scans to identify hypothalamus damage: These imaging tests are important for evaluating people showing possible signs and symptoms of aHO, even if there is no known history of hypothalamic injury.
- blood tests to measure hormone levels: Damage to the hypothalamus and pituitary gland, a hormone-releasing gland below the hypothalamus, may lead to hormone deficiencies detectable in blood tests. Pituitary hormones, which can affect growth and sexual development in children and adolescents, are among those that can be affected.
- resting energy expenditure test: Used to measure the rate of energy use at rest, which is typically lower than normal in people with aHO. The test is usually performed after a period of fasting and involves measuring oxygen consumption and carbon dioxide production while a person is resting to estimate the number of calories burned.
- screening for other symptoms of hypothalamic damage: aHO may co-occur with other symptoms. These symptoms, which can include behavioral problems, sleep issues, and problems with body temperature regulation, may help doctors distinguish aHO from other forms of obesity.
Ruling out other causes of weight gain
aHO symptoms can overlap with other disorders, so doctors need to rule out other possible causes of rapid weight gain, such as:
- changes in diet or physical activity
- treatment with certain medications, such as steroids and some antidepressants
- genetic disorders that may cause excessive hunger and rapid weight gain, including Bardet-Biedl syndrome (BBS) and Prader-Willi syndrome (PWS)
Unexplained rapid weight gain after hypothalamic damage is a key clinical feature of aHO. People experiencing these changes may want to consult specialists in hormonal disorders that affect the brain (neuroendocrinologists) to help with diagnosis.
Diagnosis in children vs. adults
Pediatric aHO diagnosis generally follows similar criteria to adult aHO diagnosis. However, doctors may look for unique signs and symptoms in children and adolescents and use different thresholds for assessing clinically meaningful weight gain and obesity.
Scroll horizontally to view all columns -->
| aHO diagnosis in children | aHO diagnosis in adults |
|---|---|
| Doctors may look for symptoms like short height, delayed or early puberty | Developmental symptoms don’t occur in adults, although they may have other hormone-related problems, such as low sex drive or fertility problems |
| Clinically meaningful BMI change is relative to children of the same age and sex | A BMI increase of at least 5% is considered clinically meaningful |
| Reaching a level of obesity corresponding to a BMI higher than about 97%-98% of children of the same age and sex | Reaching a level of obesity corresponding to a BMI of 25 kg/m2 or higher, or to a BMI of 30 kg/m2 or higher, depending on racial and ethnic background |
Doctors may also be more concerned about BBS, PWS, or other genetic causes of obesity in children, because these disorders typically manifest in childhood. Genetic testing can help confirm or rule out these conditions.
After diagnosis
After receiving a diagnosis, people with aHO should work with their healthcare team to plan for long-term monitoring and care. This will likely involve visits to hormone specialists, such as endocrinologists or neuroendocrinologists, as well as multidisciplinary support from other healthcare professionals, therapists, and dietitians.
Close monitoring is recommended to detect signs of possible obesity-related complications, which may include:
- metabolic dysfunction-associated steatotic liver disease, a type of fatty liver disease
- type 2 diabetes
- sleep apnea, a condition in which breathing is interrupted during sleep
- depression, anxiety, or other mental health issues
For people with a history of brain tumors, doctors will likely also monitor patients for signs of tumor recurrence.
By establishing a clear diagnosis through specialized testing and symptom evaluation, patients and their care teams can shift their focus toward long-term management strategies to stabilize weight and prevent future health complications.
Rare Obesity News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
